{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:25:32Z","timestamp":1762003532922},"reference-count":31,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The introduction of enzyme supplementation therapy for Gaucherdisease has had a great impact on the lives of many patients. Organomegaly, cytopenia and bone disease have been shown to improve in response to treatment, resulting in an improvement in quality of life. However, the assessment of organ system involvement is not always done in such a way that the relationship with clinically relevant endpoints is clear. The lack of adequately validated methods of assessment, especially for bone disease, has hindered the establishment of treatment goals and guidelines for treatment optimization.<\/jats:p>","DOI":"10.1023\/a:1012492429191","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T13:38:06Z","timestamp":1040650686000},"page":"97-105","source":"Crossref","is-referenced-by-count":56,"title":["Clinically relevant therapeutic endpoints in type I Gaucher disease"],"prefix":"10.1002","volume":"24","author":[{"given":"C. E. M.","family":"Hollak","sequence":"first","affiliation":[{"name":"Department of Hematology F4\u2010224 Academic Medical Center  P.O. BOX 2660 Amsterdam 1100 DD The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maas","sequence":"additional","affiliation":[{"name":"Department of Hematology F4\u2010224 Academic Medical Center  P.O. BOX 2660 Amsterdam 1100 DD The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Aerts","sequence":"additional","affiliation":[{"name":"Department of Hematology F4\u2010224 Academic Medical Center  P.O. BOX 2660 Amsterdam 1100 DD The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,4]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80034-0"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1995.0012"},{"key":"e_1_2_1_5_1","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"Beutler E","year":"1995"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.40.25680"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2835"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.16.1754"},{"issue":"12","key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1177\/009127000004001212","article-title":"Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development","volume":"40","author":"Colburn WA","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80033-9"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92555-8"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008814105603"},{"key":"e_1_2_1_13_1","first-page":"18","volume-title":"Abstract, 3rd Meeting of the European Working Group on Gaucher Disease","author":"Ek M","year":"1999"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1996.0016"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212033272304"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199652020-00001"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01616.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91037-9"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00134-4"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2076.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117084"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.182.2.1732964"},{"key":"e_1_2_1_23_1","first-page":"40","volume-title":"Abstract, 3rd Meeting of the European Working Group on Gaucher Disease","author":"Maas M","year":"1999"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008859420641"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(96)90183-3"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.275.7.548"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.2.408.408"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-199905000-00029"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.139.6.1202"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.96.4.629"},{"key":"e_1_2_1_31_1","first-page":"71","volume-title":"Abstract, 3rd Meeting of the European Working Group on Gaucher Disease","author":"Van Weely S","year":"1999"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90042-6"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1023%2FA%3A1012492429191","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1023\/A%3A1012492429191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:35:04Z","timestamp":1694781304000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1023\/A%3A1012492429191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":31,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1023\/A:1012492429191"],"URL":"https:\/\/doi.org\/10.1023\/a:1012492429191","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}